Marleen Depré

Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy Volunteers

Anne Van Hecken, Jules I. Schwartz, Marleen Depré et al. · The Journal of Clinical Pharmacology · 2000 · 355 citations

Medicine, Pharmacology, Pharmacotherapy +13

The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake

Carol Addy, Hamish Wright, Koen Van Laere et al. · Cell Metabolism · 2008 · 200 citations · Full text

Life Sciences, Nutritional Sciences, Pharmacology +14

Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion

K. Six, Tinne Daems, Jan de Hoon et al. · European Journal of Pharmaceutical Sciences · 2005 · 170 citations

Pharmacy, Materials Science, Pharmaceutics +16

The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo

Zuzana Diamant, Mieke Timmers, H. van der Veen et al. · Journal of Allergy and Clinical Immunology · 1995 · 157 citations

Life Sciences, Immunology, Pharmacology +15

Tolerance and pharmacokinetics of propacetamol, a paracetamol formulation for intravenous use

Marleen Depré, A. Van Hecken, René Verbesselt et al. · Fundamental and Clinical Pharmacology · 1992 · 114 citations

Pharmacy, Pharmacokinetics, Pharmacology +10